Viewing StudyNCT06256627



Ignite Creation Date: 2024-05-06 @ 8:06 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06256627
Status: RECRUITING
Last Update Posted: 2024-02-13
First Post: 2024-02-05

Brief Title: The Maintenance Treatment of ITIVA in AML Patients
Sponsor: Henan Cancer Hospital
Organization: Henan Cancer Hospital

Conditions & Keywords Data

Conditions:
Name
Azacitidine
Acute Myeloid Leukemia
Maintenance Treatment
Minor Residue Disease
Interferon-α-1b
Interleukin-2
Thalidomide
Venentoclax
Keywords: